WI

William H. Frey, II

HF Healthpartners Research Foundation: 30 patents #1 of 25Top 4%
HE Healthpartners Research & Education: 10 patents #1 of 10Top 10%
CH Chiron: 6 patents #94 of 583Top 20%
Stanford University: 5 patents #462 of 5,197Top 9%
TR Trigemina: 5 patents #2 of 6Top 35%
HI Healthpartners Institute: 4 patents #1 of 9Top 15%
BI Baxalta Incorporated: 2 patents #67 of 230Top 30%
UM University of Minnesota: 2 patents #696 of 2,951Top 25%
SI Sri International: 1 patents #681 of 1,272Top 55%
TL Takeda Pharmaceutical Company Limited: 1 patents #859 of 1,531Top 60%
RF Ramsey Foundation: 1 patents #4 of 8Top 50%
GE Geron: 1 patents #93 of 147Top 65%
University of California: 1 patents #8,022 of 18,278Top 45%
📍 White Bear Lake, MN: #5 of 561 inventorsTop 1%
🗺 Minnesota: #720 of 52,454 inventorsTop 2%
Overall (All Time): #44,433 of 4,157,543Top 2%
56
Patents All Time

Issued Patents All Time

Showing 26–50 of 56 patents

Patent #TitleCo-InventorsDate
9211272 Method of treating lewy body syndrome comprising administering metal chelators to the upper one-third of the nasal cavity Samuel Scott Panter, Leah Ranae Bresin Hanson 2015-12-15
9211273 Methods of treating neurodegeneration caused by iron accumulation in the brain comprising administering metal chelators to the upper one-third of the nasal cavity Samuel Scott Panter, Leah Ranae Bresin Hanson 2015-12-15
9205066 Method of treating parkinson's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavity Leah Ranae Bresin Hanson, Samuel Scott Panter 2015-12-08
9072756 Methods and compositions for increasing the efficacy of an agent that directly or indirectly affects a muscarinic receptor through administration of a pyrophosphate analog John Randall Fawcett 2015-07-07
8772263 Methods and compositions for protecting or treating muscarinic receptors through administration of pyrophosphate analog in subjects exposed to toxic or carcinogenic metals or metal ions John Randall Fawcett 2014-07-08
8771681 Methods and compositions for protecting and treating muscarinic receptors by administering a pyrophosphate analog to a subject exposed to bacterial, fungal, viral, prion or algal infection John Randall Fawcett 2014-07-08
8765711 Method for protecting and treating at least one muscarinic receptor from dysfunction resulting from free radical damage John Randall Fawcett 2014-07-01
8622993 Device and method for delivering therapeutic substances to the maxillary sinus of a patient Neil Jeremy Johnson 2014-01-07
8609088 Intranasal delivery of therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases Daniel A. Wolf, R. Scott McIvor, Leah Ranae Bresin Hanson 2013-12-17
8592485 Methods and pharmaceutical compositions for treating the animal central nervous system for psychiatric disorders Leah Ranae Bresin Hanson 2013-11-26
8568691 Methods for providing neuroprotection for the animal central nervous system against the effects of ischemia, neurodegeneration, trauma, and metal poisoning Samuel Scott Panter, Leah Ranae Bresin Hanson 2013-10-29
8501691 Methods for treatment of headaches by administration of oxytocin David C. Yeomans, Martin S. Angst, Daniel I. Jacobs 2013-08-06
8283160 Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system Lusine Danielyan, Christoph Gleiter 2012-10-09
8258096 Therapy procedure for drug delivery for trigeminal pain David C. Yeomans, Daniel I. Jacobs, Martin S. Angst 2012-09-04
8252745 Methods for treatment of headaches by administration of oxytocin David C. Yeomans, Martin S. Angst, Daniel I. Jacobs 2012-08-28
8202838 Methods for treatment of headaches by administration of oxytocin David C. Yeomans, Martin S. Angst, Daniel I. Jacobs 2012-06-19
8198240 Methods for treatment of headaches by administration of oxytocin David C. Yeomans, Martin S. Angst, Daniel I. Jacobs 2012-06-12
8153604 CNS-tumor treatment method and composition Dennis F. Deen, Sergei Gryaznov 2012-04-10
7989502 Intranasal delivery of modafinil Mary Ann Katherine Greco, Jacqueline DeRose, Rachel Beth Matthews, Leah Ranae Bresin Hanson 2011-08-02
7972595 Methods and compositions for protecting and treating at least one muscarinic receptor from dysfunction not resulting from oxidative stress, toxic actions of metals or infectious agents by administering a pyrophosphate analog John Randall Fawcett 2011-07-05
7786166 Methods and compositions for protecting and treating muscarinic receptors through administration of at least one protective agent John Randall Fawcett 2010-08-31
7776312 Method of treating Alzheimer's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavity Samuel Scott Panter, Leah Ranae Bresin Hanson, Annina Roeytenberg 2010-08-17
7618615 Methods for providing neuroprotection for the animal central nervous system against neurodegeneration caused by ischemia Samual Panter, Leah Ranae Bresin Hanson 2009-11-17
7273618 Method for administering agents to the central nervous system Robert Gary Thorne 2007-09-25
7084126 Methods and compositions for enhancing cellular function through protection of tissue components John Randall Fawcett 2006-08-01